Coya Therapeutics, Inc.
COYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38,340 | $32,627 | $5,934 | $4,340 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $731 | $7,500 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5,238 | $1,070 | $1,251 | $244 |
| Total Curr. Assets | $44,308 | $41,196 | $7,185 | $4,584 |
| Property Plant & Equip (Net) | $39 | $66 | $93 | $121 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1,117 | $87 |
| Total NC Assets | $39 | $66 | $1,211 | $208 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $44,347 | $41,262 | $8,396 | $4,792 |
| Liabilities | – | – | – | – |
| Payables | $1,588 | $1,156 | $1,815 | $858 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $724 | $0 | $0 |
| Deferred Revenue | $848 | $923 | $0 | $0 |
| Other Curr. Liab. | $1,388 | $2,249 | $2,008 | $291 |
| Total Curr. Liab. | $3,824 | $5,052 | $3,824 | $1,148 |
| LT Debt | $0 | $0 | $12,965 | $0 |
| Deferred Rev, NC | $945 | $575 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $945 | $575 | $12,965 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4,770 | $5,627 | $16,789 | $1,148 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $8,794 | $8,794 |
| Common Stock | $2 | $1 | $0 | $0 |
| Retained Earnings | -$40,737 | -$25,856 | -$17,869 | -$5,624 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $80,313 | $61,491 | $681 | $474 |
| Total Equity | $39,577 | $35,636 | -$8,394 | $3,644 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $44,347 | $41,262 | $8,396 | $4,792 |
| Net Debt | -$38,340 | -$32,627 | $7,032 | -$4,340 |